TD Cowen analyst Bryan Bergin maintained a Hold rating on Paychex (PAYX – Research Report) today and set a price target of $146.00. The ...

In a report released today, Andrew Kligerman from TD Cowen maintained a Hold rating on Progressive (PGR – Research Report), with a price target ...

TD Cowen analysts estimate that about 45% of U.S. sales for Ozempic and Rybelsus each goes through Medicare Part D.

Gautam Khanna, analyst at TD Cowen, shares his outlook for Boeing and says it will take "a number of years" before the ...

Pembina Pipeline (NYSE:PBA) +0.5% in Wednesday's trading as analysts at TD Cowen call the stock its top pick for Canadian ...

SAP stock upgraded to Buy by TD Cowen, citing rise in ERP priority and AI driving cloud migrations. Read more here.

Broadcom Inc (AVGO) stock saw a modest uptick, ending the day at $229.41 which represents a slight increase of $1.41 or 0.62% from the prior close of $228. The stock opened at $235.22 and touched a ...

With a finite number of carriers in most regions, the LTL industry is much more disciplined on pricing than the highly ...

Blue Owl Capital Inc (OWL) stock saw a modest uptick, ending the day at $23.4 which represents a slight increase of $0.49 or 2.14% from the prior close of $22.91. The stock opened at $23.15 and ...

The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.

TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene is differentiated by its “superior” efficacy and ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...